Celldex Therapeutics
CLDX
CLDX
174 hedge funds and large institutions have $1.86B invested in Celldex Therapeutics in 2024 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 66 increasing their positions, 48 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 176 → 174 (-2)
24% less capital invested
Capital invested by funds: $2.44B → $1.86B (-$579M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
174
Holding in Top 10
3
Calls
$24.9M
Puts
$17.1M
Top Buyers
| 1 | +$59.9M | |
| 2 | +$40.6M | |
| 3 | +$38.9M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$23.9M |
| 5 |
Morgan Stanley
New York
|
+$23M |
Top Sellers
| 1 | -$55M | |
| 2 | -$45M | |
| 3 | -$30.6M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$29.5M |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$29.2M |